<DOC>
	<DOCNO>NCT01744574</DOCNO>
	<brief_summary>Data suggest progesterone may improve smoke cessation outcome perhaps reduce impulsive behavior . However , clinical literature topic lack . Therefore , Project I propose double-blind randomize control trial ass role exogenous progesterone impulsivity smoke cessation sample male female motivate quit smoking .</brief_summary>
	<brief_title>Sex Differences , Hormones &amp; Smoking Cessation</brief_title>
	<detailed_description>Subjects stratify sex randomly assign active progesterone ( PRO ) placebo ( PBO ) . Telephone screen visit invitation lead consent process in-person screen include medical-psychiatric evaluation inclusion/exclusion , randomization medication induction , stable medication medication reduction final evaluation secondary outcome .</detailed_description>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Male 18 60 year old Female 18 50 year old Selfreport regular smoking Motivated quit smoking In stable physical/mental health Self report regular menstrual cycle ( female ) English fluency Understand study procedure able provide inform consent Ability participate fully research element duration trial . Current recent ( &lt; 3 month ) breastfeeding ( female ) Current plan pregnancy within next three month ( female ) Conditions contraindicate progesterone treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>